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The IBD2 locus on chromosome 12 has been linked to both Crohn disease (CD) and ulcerative colitis (UC) but
has not been detected in some CD-dominated data sets. In the present study, we genotyped 581 relative pairs with
inflammatory bowel disease (252 from CD-only families, 138 from UC-only families, and 191 from mixed families
containing cases of both CD and UC), using 12 markers spanning the IBD2 locus. A GENEHUNTER-PLUS
multipoint LOD score of 3.91 was detected for pairs from UC-only families, compared with 1.66 for CD-only and
1.29 for mixed families. The difference between the LOD scores for UC and CD was significant in two different
tests for heterogeneity ( for one test and for the other). IBD2 thus appears to make a majorPp .0057 Pp .0375
contribution to UC susceptibility but to have only a relatively minor effect with regard to CD, for which there
may be substantially more locus heterogeneity.
Crohn disease (CD [MIM 266600]) and ulcerative colitis
(UC [MIM 191390]), the two common forms of inflam-
matory bowel disease (IBD), have a combined preva-
lence, in populations of northern European origin, of
150–200/100,000. Evidence for a strong genetic contri-
bution to IBD comes from twin studies, which demon-
strate a substantially higher rate of disease concordance
in MZ compared with DZ twins, and from family stud-
ies, which demonstrate consistently high ls scores (sib-
ling risk/population prevalence). This is particularly true
for CD ( ; twin concordance MZ:DZ pl p 20–35s
36%:12%) and, to a lesser extent, for UC ( ;l p 8–15s
twin concordance MZ:DZ p 12%:3%) (Tysk et al.
1988; Probert et al. 1993; Satsangi et al. 1994; Subhani
et al. 1998).
Although genetic susceptibility is clearly important,
the inheritance of IBD is complex. Furthermore, the eti-
ologic basis of the relationship between CD and UC is
as yet unexplained. Some phenotypic features are shared;
Received August 16, 2000; accepted for publication October 10,
2000; electronically published November 10, 2000.
Address for correspondence and reprints: Dr. Richard H. Duerr,
565 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 1526. E-mail:
duerr@msx.dept-med.pitt.edu
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6706-0029$02.00
up to 10% of cases are classified as indeterminate; and
the two forms of IBD run together within a single ped-
igree in ∼30% of multiply affected families (Kirsner
1973; Satsangi et al. 1994). However, there are also some
notable epidemiological differences—for example, in
sibling recurrence risk and in twin concordance rates
(Tysk et al. 1988; Probert et al. 1993; Subhani et al.
1998)—and CD and UC remain distinct clinical entities
with separate patterns of behavior. The genetic model
that best fits is therefore one in which CD and UC are
related polygenic diseases that may share some suscep-
tibility loci but differ at others.
Genome scanning in IBD has established a number of
replicated regions of linkage, including loci on chro-
mosomes 3, 6, 12, 14, and 16. The candidate region on
chromosome 12 (the IBD2 locus [MIM 601458]) has
been reported for both CD and UC (Satsangi et al. 1996;
Akolkar et al. 1998; Curran et al. 1998; Duerr et al.
1998; Hampe et al. 1999; Ma et al. 1999), whereas the
region on chromosome 16 (the IBD1 locus [MIM
266600]) appears to be linked exclusively to CD (Hugot
et al. 1996; Ohmen et al. 1996; Parkes et al. 1996; Brant
et al. 1998; Cavanaugh et al. 1998; Cho et al. 1998;
Curran et al. 1998; Annese et al. 1999; Hampe et al.
1999; IBD Genetics Consortium 2000).
Although the chromosome 12 linkage has been rep-
1606 Am. J. Hum. Genet. 67:1605–1610, 2000
Table 1
Number of Families and Number of Genotyped Affected Relative Pairs
CATEGORY All IBD CD Only Mixed UC Only
U.K. families 171 79 30 62
Genotyped affected relative pairs 222 100 45 77
Sib pairs 199 93 35 71
Half-sib pairs 1 0 0 1
Avuncular pairs 18 6 7 5
Grandparent-grandchild pairs 1 0 1 0
First-cousin pairs 3 1 2 0
U.S. families 196 86 73 37
Genotyped affected relative pairs 359 152 146 61
Sib pairs 197 106 59 32
Half-sib pairs 6 5 1 0
Avuncular pairs 67 23 32 12
Grandparent-grandchild pairs 4 0 2 2
First-cousin pairs 46 12 23 11
Other, more distant pairs 39 6 29 4
Total families 367 165 103 99
Total genotyped affected relative pairs 581 252 191 138
licated in a number of data sets (Satsangi et al. 1996;
Akolkar et al. 1998; Curran et al. 1998; Duerr et al.
1998; Hampe et al. 1999; Ma et al. 1999), it has not
been found in all, and three studies claimed to exclude
this region for a locus-specific (Brant et al. 1998;l 1 2s
Rioux et al. 1998; Vermeire et al. 2000). There are many
precedents for failure to replicate linkages in complex
diseases—and many possible explanations, particularly
relating to power (Suarez et al. 1994; Mandal et al.
1999), but we were struck by the fact that the studies
that have failed to detect linkage between IBD and the
chromosome 12 locus have contained few relative pairs
with UC. The aim of the current study, therefore, was
to evaluate further the IBD2 locus in a large panel of
multiply affected families and, specifically, to determine
its relative contribution to CD susceptibility and UC
susceptibility.
Ethical approval for this work was given by the Cen-
tral Oxford Research and Ethics Committee and the Uni-
versity of Pittsburgh Institutional Review Board for Bi-
omedical Research. The panel of U.K. and U.S. families
studied are described in table 1. A total of 581 IBD-
affected relative pairs were genotyped, including 396
affected sib pairs. There were 252 affected relative pairs
from CD-only families, 138 pairs fromUC-only families,
and 191 pairs from families in which cases of UC and
CD coexisted (“mixed” families). Case notes were re-
viewed to confirm the diagnoses. All individuals in the
panel were white European in origin. Ashkenazi Jewish
ethnicity was reported in 43 (11.7%) of the 367 families.
The U.K. and U.S. panels each included families used
and described in earlier studies, in addition to families
more recently recruited, particularly with regard to the
U.S. panel (Satsangi et al. 1996; Duerr et al. 1998).
Twelve markers spanning the peak of the chromosome
12 candidate interval, as defined in previous reports by
both our group and others (Satsangi et al. 1996; Akolkar
et al. 1998; Curran et al. 1998; Duerr et al. 1998; Hampe
et al. 1999; Ma et al. 1999), were studied in the com-
bined U.K./U.S. panel. Each microsatellite was amplified
by PCR using fluorescence-labeled oligoprimers. The flu-
orescently labeled PCR amplimers were electrophoresed
and detected on ABI 373 and 377 DNA sequencers (Ap-
plied Biosystems) and were genotyped by either GENE-
SCAN/GENOTYPER (Applied Biosystems) (U.K. panel)
or TrueAllele (Cybergenetics) (U.S. panel) software. A
control DNA, CEPH 1347-02, was run on each geno-
typing gel, and the results were used to standardize allele
calls between gels and between the two genotyping labs.
Genotyping data were checked for Mendelian inconsis-
tencies, by PEDCHECK (O’Connell and Weeks 1998
[also see the University of Pittsburgh Division of Statis-
tical Genetics Web page]).
Marker order was determined by radiation-hybrid
mapping using Genebridge 4 and Stanford TNG panels
(both from Research Genetics). Map distances were cal-
culated by the ILINK function of the VITESSE package
(O’Connell and Weeks 1995 [also see the University of
Pittsburgh Division of Statistical Genetics Web page]),
on the basis of genotyping data from the family panel
and of calculation of multipoint distances between over-
lapping sets of four markers.
Single- and multipoint linkage analyses were per-
formed by GENEHUNTER-PLUS (Kong and Cox 1997
[also see those authors’ GENEHUNTER-PLUS Web
page, for GENEHUNTER-PLUS version 1.2]). This mod-
ified version of the GENEHUNTER program (Krug-
lyak et al. 1996) uses a simple one-parameter linear
model to compute a nonparametric LOD score, analo-
gous to a parametric LOD score, which can be used for
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Table 2
Single-Point GENEHUNTER-PLUS LOD Scores for 12 Markers Studied in the Combined U.K./U.S. Panel
MAP
POSITIONa
(cM)
MICROSATELLITE
LOCUS
HETEROZYGOSITY
(%)
NO. OF
ALLELES
OBSERVED
GENEHUNTER-PLUS SINGLE-POINT
LOD SCORE FOR
All IBD CD Only Mixed UC Only
0.0 D12S85 68.2 13 2.31 .28 1.23 1.13
5.3 D12S368 82.5 9 2.62 .38 1.59 1.11
6.8 D12S1586 84.6 13 3.11 .25 .52 3.78
8.1 D12S1724 78.5 13 5.21 1.52 1.45 2.49
10.9 D12S90 76.2 11 4.20 1.59 1.23 1.41
11.6 D12S305 66.8 10 2.09 .54 .88 .80
12.5 D12S1700 78.7 14 2.63 .30 1.57 1.43
13.1 D12S1056 70.0 6 3.25 .97 .71 1.87
13.6 D12S1662 71.6 9 4.41 1.01 .77 3.48
14.4 D12S83 77.4 13 5.26 1.35 2.09 2.05
15.1 D12S1655 70.4 9 2.02 .56 .65 .95
25.1 D12S335 80.7 14 1.18 .01 .12 2.58
a Marker order was determined by radiation-hybrid mapping, and genetic distance was computed by the
VITESSE package.
construction of support regions and for comparison of
loci. Our analysis used the Spairs statistic, which measures
identity-by-descent allele sharing between all pairs of
affected relatives. The panel was considered as a whole
(IBD overall) and then was divided into UC-only, CD-
only, and mixed family subsets.
The results of single-point linkage analysis of the 12
markers studied are presented in table 2. The highest
single-point LOD score for IBD overall occurred at
D12S83 (LOD score 5.26). Most of the support for link-
age comes from the 138 affected relative pairs from UC-
only families, in whom the peak single-point LOD score
was 3.78 at D12S1586, compared with a peak LOD
score of 1.59 at D12S90 in the 252 affected pairs from
CD-only families and a peak LOD score of 2.09 at
D12S83 in the 191 affected pairs from mixed families.
Results of the multipoint linkage analysis are pre-
sented in figure 1. The peak GENEHUNTER-PLUS
LOD score for IBD overall was 5.19. A maximum LOD
score of 3.91 was observed in the UC-only families,
compared with 1.66 in the CD-only families and 1.29
in the mixed families. The discrepancy of 7 cM between
the peaks of the linkage curves for UC and CD, reflected
in the two peaks of the IBD curve, probably reflects
the limited resolution of haplotype-sharing methods
of linkage analysis for fine mapping in polygenic dis-
eases (Kruglyak and Lander 1996). However, it is also
possible that there is more than one IBD-susceptibility
gene in this region, with these exerting differential ef-
fects in UC and CD. A precedent for detection of more
than one gene per linkage interval comes from fine
mapping in mouse models of type 1 diabetes (Podolin
et al. 1998).
To formally test for heterogeneity between the UC-
only and CD-only families, two simulation studies were
employed. In the first simulation study, we examined
the probability of obtaining the GENEHUNTER-PLUS
LOD-score difference that we observed under the null
hypothesis of no linkage. For the second simulation
study, we examined the probability of randomly dividing
our sample into two groups similar in size to our UC-
only and CD-only families and achieving a similarly high
difference in GENEHUNTER-PLUS LOD scores. Taken
together, these two studies show that our division of
families is unique—and that the LOD-score difference
that we observed would not be obtained very often by
chance.
For the first simulation study, we used Morton’s M
test (Morton 1956):
ˆ ˆXp 2 ln (10) Z (v ) Z(v) . i i[ ]
i
This test divides a sample into n groups and then com-
pares the LOD scores in the individual groups versus
the combined LOD score in the entire sample. In the
equation above, Zi( ) is the total LOD score for theˆvi
families in the ith class ( ), and is the max-ˆip 1,… ,n vi
imum-likelihood estimate of the recombination fraction
in the ith class. The null hypothesis of no heterogeneity
between groups would be represented by the case in
which the sum of the individual groups’ LOD scores
would be exactly equal to the combined sample LOD
score (i.e., ). We simulated the dis-ˆ ˆ[S Z (v ) Z(v)]p 0i i i
tribution of this statistic to determine the P value as-
sociated with our observed statistic value. In the com-
puter simulation, random genotype data for all the
markers in the region were generated 10,000 times each
for the group of CD-only families and for the group of
UC-only families, and, each time, Morton’s M test was
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Figure 1 Results of multipoint nonparametric linkage analysis for markers across the 25-cM candidate interval on chromosome 12.
Results are given for IBD overall and for subsets containing UC-only, CD-only, and mixed families. LOD scores derived from GENEHUNTER-
PLUS (Y-axis) are plotted against distance (in cM) from D12S85.
performed using the GENEHUNTER-PLUS LOD scores
computed on the basis of the simulated data. The P value
for our observed heterogeneity statistic value was de-
termined by counting how often the simulated data pro-
duced a heterogeneity statistic value as high as our ob-
served heterogeneity statistic value. The simulations
showed that the heterogeneity statistic value that we ob-
served between the UC-only families and the CD-only
families is unlikely to occur by chance ( ) andPp .0057
that it therefore represents true evidence of heterogeneity
between these two sets of families.
The second simulation study that we performed
looked at the significance of the division of samples. For
this study, we compared the distribution of LOD scores
obtained when the available families (367) were ran-
domly split into two groups of sizes similar to those of
the UC-only and CD-only groups (99 and 165 families,
respectively). To do this, we randomly selected (without
replacement) 99 pedigrees from our sample and then
another 165 pedigrees and then calculated themaximum
GENEHUNTER-PLUS LOD scores for the new samples.
This procedure was repeated 10,000 times, to gener-
ate a distribution of GENEHUNTER-PLUS LOD-score
differences. A difference greater than or equal to our
observed UC-CD LOD-score difference (2.25) was ob-
served only 375 times in 10,000 replications (Pp
). Together, then, these two simulation studies in-.0375
dicate that we have significant heterogeneity in our sam-
ple and that clinical diagnosis is a significant factor in-
fluencing the LOD-score difference.
With the LOD score of 3.91 for UC-only families, the
results of this study provide the first evidence of a “sig-
nificant” linkage result for UC when the established ge-
nomewide criteria of Lander and Kruglyak (1995) are
used. The multipoint LOD score of 5.19 for IBD is cer-
tainly also respectable in the context of a polygenic dis-
ease. Although there is likely to be some positive bias
in these results, given that both the U.K. and the U.S.
panels contained affected relative pairs known to show
increased haplotype sharing in this region, it is also true
that the number of affected relative pairs has expanded
by a total of 39% beyond those reported originally, and
the intuitive expectation that LOD scores from different
data sets should be additive can be confounded by het-
erogeneity in the study populations.
Of interest was the impact that increasing the size of
the data set had on the LOD scores, both for IBD overall
and for the CD and UC subgroups. In the original U.K.
data set (208 affected relative pairs), peak multipoint
LOD scores were 3.87 for IBD, 1.08 for CD, and 1.54
for UC (M.P. and D.P.J., unpublished data), and in the
U.S. data set (208 affected relative pairs) they were 2.79
for IBD, 1.79 for CD, and 1.82 for UC (Duerr et al.
1998); for the two expanded data sets combined (581
affected relative pairs) the peak multipoint LOD scores
are 5.19 for IBD, 1.66 for CD, and 3.91 for UC. Thus,
although the evidence for linkage of this region to IBD
overall has increased, it can be seen that this is predom-
inantly due to an increase in the strength of linkage to
UC, with the LOD score for CD essentially unchanged
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despite the increase in genotyped families. This suggests
relatively more heterogeneity within the CD population,
at least with regard to the IBD2 locus, as well as a
stronger contribution of this region to UC susceptibility.
The latter is corroborated both by the stronger evidence
for linkage to UC compared with that to CD, despite
the substantially smaller size of the UC group (138 af-
fected relative pairs from UC-only families, compared
with 252 affected relative pairs from CD-only families),
and, in particular, by the fact that the difference between
the LOD score for UC and that for CD is significant in
the heterogeneity tests.
The apparently stronger effect that we have observed
for UC is likely to have an impact on interpretation of
future linkage reports in this region and might, in part,
explain the failure of some (CD-dominated) data sets to
show significant linkage at markers within the chro-
mosome 12 candidate interval (Brant et al. 1998; Rioux
et al. 1998; Vermeire et al. 2000). If the evidence for
linkage heterogeneity between the disease subgroups at
IBD2 is indicating a major gene effect for UC but a
relatively minor one for CD, and if there truly is more
linkage heterogeneity at IBD2 within the CD popula-
tion, then clearly this linkage will be more difficult to
detect in panels of families containing a majority of CD
relative pairs.
The picture emerging for the IBD2 locus is therefore
one of a major contribution with regard to UC suscep-
tibility but probably a relatively minor effect for CD—
with the likelihood of substantially more heterogeneity,
with regard to IBD2, for CD. Given the findings of the
current study, attempts at fine mapping the IBD2 locus
should probably focus, at least in the first instance, on
individuals and families with UC. The increasing avail-
ability of sequence data, single-nucleotide polymor-
phisms, and information regarding positional candidate
genes, together with the accumulation of ever larger IBD
subsets, can only help this process—and, thereby, help
us to understand the contribution that this locus makes
to the pathogenesis of IBD.
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